© 1997 American Heart Association, Inc.
Articles |
Neutralizing Antibodies Directed Against Osteopontin Inhibit Rat Carotid Neointimal Thickening After Endothelial Denudation
the Department of Pathology, University of Washington (D.M.L., M.M.A., S.M.S., C.M.G.), Seattle; Research Center, Hotel-Dieu Hospital (D. deB.), Montreal, Quebec, Canada; and Department of Cell Biology, Vanderbilt University (L.L.), Nashville, Tenn.
Osteopontin is an arginine-glycine-aspartate-containing acidic glycoprotein with adhesive and migratory activities in vitro. We previously showed that osteopontin was highly expressed in injured rat arteries as well as in human atherosclerotic plaques. In contrast, uninjured blood vessels make very little osteopontin. In this report, we have investigated the role of osteopontin in rat neointima formation using neutralizing antibodies. Rats were treated with either nonimmune or antiosteopontin antibody and subjected to endothelial denudation of the carotid artery by using a balloon catheter. Two weeks after injury, intimal areas and cell numbers were significantly decreased (33% and 31%, respectively) in the antiosteopontin group compared with the nonimmune IgG group. No differences in carotid medial areas or cell numbers were observed. Intimal and medial replication rates, as measured by continuous bromodeoxyuridine infusion during the final week of the experimental protocol, were not significantly different between the two groups. No gross histological changes were noted in the intimas formed in the presence of either neutralizing or nonimmune antibody. In addition, no difference in early carotid medial cell replication rate was observed when antibodies were infused for 4 days after angioplasty. These data demonstrate for the first time a functional role for osteopontin in the process of carotid neointimal thickening in vivo and suggest that osteopontin plays an active role in the remodeling processes important for human atherosclerotic and restenotic lesion development.
Key Words: osteopontin • neointima • atherosclerosis • restenosis • migration
This article has been cited by other articles:
 |
|
 |
|
  T.-Y. Chun, P. N. Chander, J.-W. Kim, J. H. Pratt, and C. T. Stier Jr. Aldosterone, but not angiotensin II, increases profibrotic factors in kidney of adrenalectomized stroke-prone spontaneously hypertensive rats Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E305 - E312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Scatena, L. Liaw, and C. M. Giachelli Osteopontin: A Multifunctional Molecule Regulating Chronic Inflammation and Vascular Disease Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2302 - 2309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Leali, E. Moroni, F. Bussolino, and M. Presta Osteopontin Overexpression Inhibits in Vitro Re-endothelialization via Integrin Engagement J. Biol. Chem., July 6, 2007; 282(27): 19676 - 19684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-F. Lai, V. Seshadri, K. Huang, J.-S. Shao, J. Cai, R. Vattikuti, A. Schumacher, A. P. Loewy, D. T. Denhardt, S. R. Rittling, et al. An Osteopontin-NADPH Oxidase Signaling Cascade Promotes Pro-Matrix Metalloproteinase 9 Activation in Aortic Mesenchymal Cells Circ. Res., June 23, 2006; 98(12): 1479 - 1489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kato, Y. Momiyama, R. Ohmori, N. Tanaka, H. Taniguchi, K. Arakawa, M. Kusuhara, H. Nakamura, and F. Ohsuzu High Plasma Levels of Osteopontin in Patients With Restenosis After Percutaneous Coronary Intervention Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): e1 - e2. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Fuster, P. R. Moreno, Z. A. Fayad, R. Corti, and J. J. Badimon Atherothrombosis and High-Risk Plaque: Part I: Evolving Concepts J. Am. Coll. Cardiol., September 20, 2005; 46(6): 937 - 954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Seipelt, C. L. Backer, C. Mavroudis, V. Stellmach, M. Cornwell, I. M. Seipelt, F. A. Schoendube, and S. E. Crawford Local delivery of osteopontin attenuates vascular remodeling by altering matrix metalloproteinase-2 in a rabbit model of aortic injury J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 355 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sahai, P. Malladi, X. Pan, R. Paul, H. Melin-Aldana, R. M. Green, and P. F. Whitington Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin Am J Physiol Gastrointest Liver Physiol, November 1, 2004; 287(5): G1035 - G1043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sahai, P. Malladi, H. Melin-Aldana, R. M. Green, and P. F. Whitington Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G264 - G273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kawamura, K. Yokote, S. Asaumi, K. Kobayashi, M. Fujimoto, Y. Maezawa, Y. Saito, and S. Mori High Glucose-Induced Upregulation of Osteopontin Is Mediated via Rho/Rho Kinase Pathway in Cultured Rat Aortic Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 276 - 281. [Abstract] [Full Text]
|
|
|
|
|
|
D. L. Myers, K. J. Harmon, V. Lindner, and L. Liaw Alterations of Arterial Physiology in Osteopontin-Null Mice Arterioscler. Thromb. Vasc. Biol., June 1, 2003; 23(6): 1021 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Matsui, S. R. Rittling, H. Okamoto, M. Inobe, N. Jia, T. Shimizu, M. Akino, T. Sugawara, J. Morimoto, C. Kimura, et al. Osteopontin Deficiency Attenuates Atherosclerosis in Female Apolipoprotein E-Deficient Mice Arterioscler. Thromb. Vasc. Biol., June 1, 2003; 23(6): 1029 - 1034. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Li, S. Oparil, S. S. Kelpke, Y.-F. Chen, and J. A. Thompson Fibroblast Growth Factor Receptor-1 Signaling Induces Osteopontin Expression and Vascular Smooth Muscle Cell-Dependent Adventitial Fibroblast Migration In Vitro Circulation, August 13, 2002; 106(7): 854 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Isoda, K. Nishikawa, Y. Kamezawa, M. Yoshida, M. Kusuhara, M. Moroi, N. Tada, and F. Ohsuzu Osteopontin Plays an Important Role in the Development of Medial Thickening and Neointimal Formation Circ. Res., July 12, 2002; 91(1): 77 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Sodhi, S. A. Phadke, D. Batlle, and A. Sahai Hypoxia Stimulates Osteopontin Expression and Proliferation of Cultured Vascular Smooth Muscle Cells: Potentiation by High Glucose Diabetes, June 1, 2001; 50(6): 1482 - 1490. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. P. Sodhi, S. A. Phadke, D. Batlle, and A. Sahai Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis: role of osteopontin Am J Physiol Renal Physiol, April 1, 2001; 280(4): F667 - F674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Li, Y.-F. Chen, S. S. Kelpke, S. Oparil, and J. A. Thompson Estrogen Attenuates Integrin-{beta}3-Dependent Adventitial Fibroblast Migration After Inhibition of Osteopontin Production in Vascular Smooth Muscle Cells Circulation, June 27, 2000; 101(25): 2949 - 2955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. TAKEMOTO, K. YOKOTE, M. YAMAZAKI, A. L. RIDALL, W. T. BUTLER, T. MATSUMOTO, K. TAMURA, Y. SAITO, and S. MORI Enhanced Expression of Osteopontin by High Glucose: Involvement of Osteopontin in Diabetic Macroangiopathy Ann. N.Y. Acad. Sci., May 1, 2000; 902(1): 357 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Dong and P. J. Goldschmidt-Clermont Bone Sialoprotein and the Paradox of Angiogenesis Versus Atherosclerosis Circ. Res., April 28, 2000; 86(8): 827 - 828. [Full Text] [PDF]
|
|
|
|
|
|
M. Takemoto, K. Yokote, M. Nishimura, T. Shigematsu, T. Hasegawa, S. Kon, T. Uede, T. Matsumoto, Y. Saito, and S. Mori Enhanced Expression of Osteopontin in Human Diabetic Artery and Analysis of Its Functional Role in Accelerated Atherogenesis Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 624 - 628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kuykindoll, H Nishimura, D. Thomason, and S. Nishimoto Osteopontin expression in spontaneously developed neointima in fowl (Gallus gallus) J. Exp. Biol., January 1, 2000; 203(2): 273 - 282. [Abstract] [PDF]
|
|
|
|
 |
|
 X. Q. Yu, J.-M. Fan, D. J. Nikolic-Paterson, N. Yang, W. Mu, R. Pichler, R. J. Johnson, R. C. Atkins, and H. Y. Lan IL-1 Up-Regulates Osteopontin Expression in Experimental Crescentic Glomerulonephritis in the Rat Am. J. Pathol., March 1, 1999; 154(3): 833 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Wada, M. D. McKee, S. Steitz, and C. M. Giachelli Calcification of Vascular Smooth Muscle Cell Cultures : Inhibition by Osteopontin Circ. Res., February 5, 1999; 84(2): 166 - 178. [Abstract] [Full Text] [PDF]
|
|